PROCLEIX® WNV Assay

Built-in flexibility to meet your needs

  • Designed for both low- and high-volume testing on the PROCLEIX® System.
  • Choose Individual Donor Testing (IDT) or select a pool size of 4, 8 or 16 with PROCLEIX® CPT Pooling Software.

Optimized for maximum efficiency

  • Throughput of up to 3,008 results in pools of 16 or up to 188 IDT results per operator.
  • Results available in 5 to 6 hours.

Unsurpassed performance1

  • 97% detection at 10 copies/mL in Analytical Sensitivity studies
  • Clinical Specificity: ~ 99.9%
  • Detects both Lineage 1 and 2 viruses with similar sensitivity
PROCLEIX is a trademark of Novartis Vaccines and Diagnostics, Inc.
Developed by Gen-Probe in collaboration with Novartis Vaccines and Diagnostics, Inc. Manufactured by Gen-Probe Incorporated. Distributed by Novartis Vaccines and Diagnostics, Inc.

 

 

References

  1. PROCLEIX WNV Assay package insert